CLINICAL_TRIALS
trial_result
· 2019-07-18
Clinical Trial Update: Rimeporide in Patients With Duchenne Muscular Dystrophy [Phase 1]
Summary
Phase 1 trial update for rimeporide in Duchenne muscular dystrophy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EspeRare Foundation | Conditions: Muscular Dystrophy, Duchenne | Phase 1 | Status: COMPLETED | Results posted: 2019-07-18